Global Artificial Intelligence (AI) in Cancer Supply, Demand and Key Producers, 2026-2032
The global Artificial Intelligence (AI) in Cancer market size is expected to reach $ 8031 million by 2032, rising at a market growth of 18.2% CAGR during the forecast period (2026-2032).
Artificial Intelligence (AI) in Cancer refers to the application of machine learning, deep learning, and data-driven computational models across the oncology care continuum to support cancer screening, diagnosis, treatment planning, and outcome prediction. AI systems in oncology analyze large volumes of heterogeneous data, including medical imaging, digital pathology slides, genomic and multi-omics data, and real-world clinical records, to detect patterns that exceed human cognitive limits. In clinical practice, these solutions function primarily as decision-support tools, improving diagnostic accuracy, standardizing interpretation, accelerating workflows, and enabling more personalized treatment strategies. Rather than replacing oncologists, AI augments clinical expertise by reducing variability and supporting earlier and more consistent cancer detection and management.
From a multi-angle classification and parameterization perspective, the market can be segmented by clinical application stage (screening and early detection, diagnosis and classification, treatment planning, therapy monitoring, and prognosis), by data modality (imaging-based, pathology-based, genomics-based, clinical data-driven, or multimodal fusion), and by cancer type (lung, breast, colorectal, prostate, hematologic, and rare cancers). Additional parameters that differentiate solutions include sensitivity and specificity at defined clinical thresholds, explainability of AI outputs, integration with hospital IT systems, regulatory clearance status, and scalability across institutions and geographies.
The industry value chain begins upstream with data generation and infrastructure providers, including imaging equipment manufacturers, sequencing platforms, digital pathology scanners, and cloud computing services. Midstream players consist of AI oncology solution developers that curate datasets, train models, and package algorithms into regulated software or integrated platforms. Downstream customers include hospitals, cancer centers, diagnostic laboratories, pharmaceutical companies, and population-level screening programs, often adopting AI tools through enterprise licenses or software-as-a-service models.
From a profitability standpoint, AI in Cancer solutions typically exhibit gross margins in the 65?85% range, reflecting their software-centric economics once development and regulatory costs are absorbed. Cloud-based platforms and AI-as-a-service models tend to achieve the highest margins, while device-embedded solutions trade some margin for faster adoption through OEM partnerships. Market growth is driven by rising cancer incidence, shortages of oncology specialists, increasing data complexity, and the shift toward precision medicine. Key trends include multimodal data integration, expansion from detection to outcome prediction, deeper OEM and hospital integration, and growing use of AI to support value-based oncology care.
This report studies the global Artificial Intelligence (AI) in Cancer demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence (AI) in Cancer, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence (AI) in Cancer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Intelligence (AI) in Cancer total market, 2021-2032, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Artificial Intelligence (AI) in Cancer total market, key domestic companies, and share, (USD Million)
Global Artificial Intelligence (AI) in Cancer revenue by player, revenue and market share 2021-2026, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by Type, CAGR, 2021-2032, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Artificial Intelligence (AI) in Cancer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PathAI, PaigeAI, Lunit, INFERVISION TECHNOLOGY, Aidoc, VUNO, Inc., ANNALISE-AI PTY LTD, BioMind, YITU Technology, Shukun Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Intelligence (AI) in Cancer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Artificial Intelligence (AI) in Cancer Market, By Region:
1. How big is the global Artificial Intelligence (AI) in Cancer market?
2. What is the demand of the global Artificial Intelligence (AI) in Cancer market?
3. What is the year over year growth of the global Artificial Intelligence (AI) in Cancer market?
4. What is the total value of the global Artificial Intelligence (AI) in Cancer market?
5. Who are the Major Players in the global Artificial Intelligence (AI) in Cancer market?
6. What are the growth factors driving the market demand?
Artificial Intelligence (AI) in Cancer refers to the application of machine learning, deep learning, and data-driven computational models across the oncology care continuum to support cancer screening, diagnosis, treatment planning, and outcome prediction. AI systems in oncology analyze large volumes of heterogeneous data, including medical imaging, digital pathology slides, genomic and multi-omics data, and real-world clinical records, to detect patterns that exceed human cognitive limits. In clinical practice, these solutions function primarily as decision-support tools, improving diagnostic accuracy, standardizing interpretation, accelerating workflows, and enabling more personalized treatment strategies. Rather than replacing oncologists, AI augments clinical expertise by reducing variability and supporting earlier and more consistent cancer detection and management.
From a multi-angle classification and parameterization perspective, the market can be segmented by clinical application stage (screening and early detection, diagnosis and classification, treatment planning, therapy monitoring, and prognosis), by data modality (imaging-based, pathology-based, genomics-based, clinical data-driven, or multimodal fusion), and by cancer type (lung, breast, colorectal, prostate, hematologic, and rare cancers). Additional parameters that differentiate solutions include sensitivity and specificity at defined clinical thresholds, explainability of AI outputs, integration with hospital IT systems, regulatory clearance status, and scalability across institutions and geographies.
The industry value chain begins upstream with data generation and infrastructure providers, including imaging equipment manufacturers, sequencing platforms, digital pathology scanners, and cloud computing services. Midstream players consist of AI oncology solution developers that curate datasets, train models, and package algorithms into regulated software or integrated platforms. Downstream customers include hospitals, cancer centers, diagnostic laboratories, pharmaceutical companies, and population-level screening programs, often adopting AI tools through enterprise licenses or software-as-a-service models.
From a profitability standpoint, AI in Cancer solutions typically exhibit gross margins in the 65?85% range, reflecting their software-centric economics once development and regulatory costs are absorbed. Cloud-based platforms and AI-as-a-service models tend to achieve the highest margins, while device-embedded solutions trade some margin for faster adoption through OEM partnerships. Market growth is driven by rising cancer incidence, shortages of oncology specialists, increasing data complexity, and the shift toward precision medicine. Key trends include multimodal data integration, expansion from detection to outcome prediction, deeper OEM and hospital integration, and growing use of AI to support value-based oncology care.
This report studies the global Artificial Intelligence (AI) in Cancer demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Intelligence (AI) in Cancer, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Intelligence (AI) in Cancer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Intelligence (AI) in Cancer total market, 2021-2032, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Artificial Intelligence (AI) in Cancer total market, key domestic companies, and share, (USD Million)
Global Artificial Intelligence (AI) in Cancer revenue by player, revenue and market share 2021-2026, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by Type, CAGR, 2021-2032, (USD Million)
Global Artificial Intelligence (AI) in Cancer total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Artificial Intelligence (AI) in Cancer market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PathAI, PaigeAI, Lunit, INFERVISION TECHNOLOGY, Aidoc, VUNO, Inc., ANNALISE-AI PTY LTD, BioMind, YITU Technology, Shukun Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Intelligence (AI) in Cancer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Artificial Intelligence (AI) in Cancer Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Medical Imaging?based AI
- Digital Pathology?based AI
- Genomics & Multi-omics AI
- Others
- Detection & Flagging
- Segmentation & Quantification
- Classification & Grading
- Prediction & Outcome Modeling
- Others
- Device-embedded AI Systems
- Standalone Software / SaaS Platforms
- AI-as-a-Service for Oncology
- Others
- Lung Cancer
- Breast Cancer
- Colorectal & GI Cancers
- Prostate & Urological Cancers
- Hematologic & Rare Cancers
- Others
- PathAI
- PaigeAI
- Lunit
- INFERVISION TECHNOLOGY
- Aidoc
- VUNO, Inc.
- ANNALISE-AI PTY LTD
- BioMind
- YITU Technology
- Shukun Technology
- Beijing Huiyi Huiying Medical Technology
- Shenzhen Keya Medical Technology
- Densitas
- Volpara
- Niramai
- MVision AI
- MammoScreen
- Perimeter Medical Imaging AI
- ICAD
- LungLifeAI
- Nanox.AI
- Varian Medical Systems
- Canon Medical
- GE Healthcare
- Philips
1. How big is the global Artificial Intelligence (AI) in Cancer market?
2. What is the demand of the global Artificial Intelligence (AI) in Cancer market?
3. What is the year over year growth of the global Artificial Intelligence (AI) in Cancer market?
4. What is the total value of the global Artificial Intelligence (AI) in Cancer market?
5. Who are the Major Players in the global Artificial Intelligence (AI) in Cancer market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Artificial Intelligence (AI) in Cancer Introduction
1.2 World Artificial Intelligence (AI) in Cancer Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Artificial Intelligence (AI) in Cancer Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.3 China Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.4 Europe Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.5 Japan Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.6 South Korea Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.7 ASEAN Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.8 India Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Intelligence (AI) in Cancer Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.2 World Artificial Intelligence (AI) in Cancer Consumption Value by Region
2.2.1 World Artificial Intelligence (AI) in Cancer Consumption Value by Region (2021-2026)
2.2.2 World Artificial Intelligence (AI) in Cancer Consumption Value Forecast by Region (2027-2032)
2.3 United States Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.4 China Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.5 Europe Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.6 Japan Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.7 South Korea Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.8 ASEAN Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.9 India Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
3 WORLD ARTIFICIAL INTELLIGENCE (AI) IN CANCER COMPANIES COMPETITIVE ANALYSIS
3.1 World Artificial Intelligence (AI) in Cancer Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Intelligence (AI) in Cancer Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Intelligence (AI) in Cancer in 2025
3.2.3 Global Concentration Ratios (CR8) for Artificial Intelligence (AI) in Cancer in 2025
3.3 Artificial Intelligence (AI) in Cancer Company Evaluation Quadrant
3.4 Artificial Intelligence (AI) in Cancer Market: Overall Company Footprint Analysis
3.4.1 Artificial Intelligence (AI) in Cancer Market: Region Footprint
3.4.2 Artificial Intelligence (AI) in Cancer Market: Company Product Type Footprint
3.4.3 Artificial Intelligence (AI) in Cancer Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Artificial Intelligence (AI) in Cancer Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Intelligence (AI) in Cancer Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Artificial Intelligence (AI) in Cancer Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Artificial Intelligence (AI) in Cancer Consumption Value Comparison
4.2.1 United States VS China: Artificial Intelligence (AI) in Cancer Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Artificial Intelligence (AI) in Cancer Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Artificial Intelligence (AI) in Cancer Companies and Market Share, 2021-2026
4.3.1 United States Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Intelligence (AI) in Cancer Revenue, (2021-2026)
4.4 China Based Companies Artificial Intelligence (AI) in Cancer Revenue and Market Share, 2021-2026
4.4.1 China Based Artificial Intelligence (AI) in Cancer Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Intelligence (AI) in Cancer Revenue, (2021-2026)
4.5 Rest of World Based Artificial Intelligence (AI) in Cancer Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Artificial Intelligence (AI) in Cancer Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Artificial Intelligence (AI) in Cancer Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Medical Imaging?based AI
5.2.2 Digital Pathology?based AI
5.2.3 Genomics & Multi-omics AI
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
5.3.2 World Artificial Intelligence (AI) in Cancer Market Size by Type (2027-2032)
5.3.3 World Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY AI FUNCTION DEPTH
6.1 World Artificial Intelligence (AI) in Cancer Market Size Overview by AI Function Depth: 2021 VS 2025 VS 2032
6.2 Segment Introduction by AI Function Depth
6.2.1 Detection & Flagging
6.2.2 Segmentation & Quantification
6.2.3 Classification & Grading
6.2.4 Prediction & Outcome Modeling
6.2.5 Others
6.3 Market Segment by AI Function Depth
6.3.1 World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth (2021-2026)
6.3.2 World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth (2027-2032)
6.3.3 World Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth (2027-2032)
7 MARKET ANALYSIS BY PRODUCT FORM & COMMERCIAL MODEL
7.1 World Artificial Intelligence (AI) in Cancer Market Size Overview by Product Form & Commercial Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form & Commercial Model
7.2.1 Device-embedded AI Systems
7.2.2 Standalone Software / SaaS Platforms
7.2.3 AI-as-a-Service for Oncology
7.2.4 Others
7.3 Market Segment by Product Form & Commercial Model
7.3.1 World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model (2021-2026)
7.3.2 World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model (2027-2032)
7.3.3 World Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Artificial Intelligence (AI) in Cancer Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Lung Cancer
8.2.2 Breast Cancer
8.2.3 Colorectal & GI Cancers
8.2.4 Prostate & Urological Cancers
8.2.5 Hematologic & Rare Cancers
8.2.6 Others
8.3 Market Segment by Application
8.3.1 World Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
8.3.2 World Artificial Intelligence (AI) in Cancer Market Size by Application (2027-2032)
8.3.3 World Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 PathAI
9.1.1 PathAI Details
9.1.2 PathAI Major Business
9.1.3 PathAI Artificial Intelligence (AI) in Cancer Product and Services
9.1.4 PathAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 PathAI Recent Developments/Updates
9.1.6 PathAI Competitive Strengths & Weaknesses
9.2 PaigeAI
9.2.1 PaigeAI Details
9.2.2 PaigeAI Major Business
9.2.3 PaigeAI Artificial Intelligence (AI) in Cancer Product and Services
9.2.4 PaigeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 PaigeAI Recent Developments/Updates
9.2.6 PaigeAI Competitive Strengths & Weaknesses
9.3 Lunit
9.3.1 Lunit Details
9.3.2 Lunit Major Business
9.3.3 Lunit Artificial Intelligence (AI) in Cancer Product and Services
9.3.4 Lunit Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Lunit Recent Developments/Updates
9.3.6 Lunit Competitive Strengths & Weaknesses
9.4 INFERVISION TECHNOLOGY
9.4.1 INFERVISION TECHNOLOGY Details
9.4.2 INFERVISION TECHNOLOGY Major Business
9.4.3 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product and Services
9.4.4 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 INFERVISION TECHNOLOGY Recent Developments/Updates
9.4.6 INFERVISION TECHNOLOGY Competitive Strengths & Weaknesses
9.5 Aidoc
9.5.1 Aidoc Details
9.5.2 Aidoc Major Business
9.5.3 Aidoc Artificial Intelligence (AI) in Cancer Product and Services
9.5.4 Aidoc Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Aidoc Recent Developments/Updates
9.5.6 Aidoc Competitive Strengths & Weaknesses
9.6 VUNO, Inc.
9.6.1 VUNO, Inc. Details
9.6.2 VUNO, Inc. Major Business
9.6.3 VUNO, Inc. Artificial Intelligence (AI) in Cancer Product and Services
9.6.4 VUNO, Inc. Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 VUNO, Inc. Recent Developments/Updates
9.6.6 VUNO, Inc. Competitive Strengths & Weaknesses
9.7 ANNALISE-AI PTY LTD
9.7.1 ANNALISE-AI PTY LTD Details
9.7.2 ANNALISE-AI PTY LTD Major Business
9.7.3 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product and Services
9.7.4 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 ANNALISE-AI PTY LTD Recent Developments/Updates
9.7.6 ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
9.8 BioMind
9.8.1 BioMind Details
9.8.2 BioMind Major Business
9.8.3 BioMind Artificial Intelligence (AI) in Cancer Product and Services
9.8.4 BioMind Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BioMind Recent Developments/Updates
9.8.6 BioMind Competitive Strengths & Weaknesses
9.9 YITU Technology
9.9.1 YITU Technology Details
9.9.2 YITU Technology Major Business
9.9.3 YITU Technology Artificial Intelligence (AI) in Cancer Product and Services
9.9.4 YITU Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 YITU Technology Recent Developments/Updates
9.9.6 YITU Technology Competitive Strengths & Weaknesses
9.10 Shukun Technology
9.10.1 Shukun Technology Details
9.10.2 Shukun Technology Major Business
9.10.3 Shukun Technology Artificial Intelligence (AI) in Cancer Product and Services
9.10.4 Shukun Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Shukun Technology Recent Developments/Updates
9.10.6 Shukun Technology Competitive Strengths & Weaknesses
9.11 Beijing Huiyi Huiying Medical Technology
9.11.1 Beijing Huiyi Huiying Medical Technology Details
9.11.2 Beijing Huiyi Huiying Medical Technology Major Business
9.11.3 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product and Services
9.11.4 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Beijing Huiyi Huiying Medical Technology Recent Developments/Updates
9.11.6 Beijing Huiyi Huiying Medical Technology Competitive Strengths & Weaknesses
9.12 Shenzhen Keya Medical Technology
9.12.1 Shenzhen Keya Medical Technology Details
9.12.2 Shenzhen Keya Medical Technology Major Business
9.12.3 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product and Services
9.12.4 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Shenzhen Keya Medical Technology Recent Developments/Updates
9.12.6 Shenzhen Keya Medical Technology Competitive Strengths & Weaknesses
9.13 Densitas
9.13.1 Densitas Details
9.13.2 Densitas Major Business
9.13.3 Densitas Artificial Intelligence (AI) in Cancer Product and Services
9.13.4 Densitas Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Densitas Recent Developments/Updates
9.13.6 Densitas Competitive Strengths & Weaknesses
9.14 Volpara
9.14.1 Volpara Details
9.14.2 Volpara Major Business
9.14.3 Volpara Artificial Intelligence (AI) in Cancer Product and Services
9.14.4 Volpara Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Volpara Recent Developments/Updates
9.14.6 Volpara Competitive Strengths & Weaknesses
9.15 Niramai
9.15.1 Niramai Details
9.15.2 Niramai Major Business
9.15.3 Niramai Artificial Intelligence (AI) in Cancer Product and Services
9.15.4 Niramai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Niramai Recent Developments/Updates
9.15.6 Niramai Competitive Strengths & Weaknesses
9.16 MVision AI
9.16.1 MVision AI Details
9.16.2 MVision AI Major Business
9.16.3 MVision AI Artificial Intelligence (AI) in Cancer Product and Services
9.16.4 MVision AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 MVision AI Recent Developments/Updates
9.16.6 MVision AI Competitive Strengths & Weaknesses
9.17 MammoScreen
9.17.1 MammoScreen Details
9.17.2 MammoScreen Major Business
9.17.3 MammoScreen Artificial Intelligence (AI) in Cancer Product and Services
9.17.4 MammoScreen Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 MammoScreen Recent Developments/Updates
9.17.6 MammoScreen Competitive Strengths & Weaknesses
9.18 Perimeter Medical Imaging AI
9.18.1 Perimeter Medical Imaging AI Details
9.18.2 Perimeter Medical Imaging AI Major Business
9.18.3 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product and Services
9.18.4 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Perimeter Medical Imaging AI Recent Developments/Updates
9.18.6 Perimeter Medical Imaging AI Competitive Strengths & Weaknesses
9.19 ICAD
9.19.1 ICAD Details
9.19.2 ICAD Major Business
9.19.3 ICAD Artificial Intelligence (AI) in Cancer Product and Services
9.19.4 ICAD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 ICAD Recent Developments/Updates
9.19.6 ICAD Competitive Strengths & Weaknesses
9.20 LungLifeAI
9.20.1 LungLifeAI Details
9.20.2 LungLifeAI Major Business
9.20.3 LungLifeAI Artificial Intelligence (AI) in Cancer Product and Services
9.20.4 LungLifeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 LungLifeAI Recent Developments/Updates
9.20.6 LungLifeAI Competitive Strengths & Weaknesses
9.21 Nanox.AI
9.21.1 Nanox.AI Details
9.21.2 Nanox.AI Major Business
9.21.3 Nanox.AI Artificial Intelligence (AI) in Cancer Product and Services
9.21.4 Nanox.AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Nanox.AI Recent Developments/Updates
9.21.6 Nanox.AI Competitive Strengths & Weaknesses
9.22 Varian Medical Systems
9.22.1 Varian Medical Systems Details
9.22.2 Varian Medical Systems Major Business
9.22.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Product and Services
9.22.4 Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Varian Medical Systems Recent Developments/Updates
9.22.6 Varian Medical Systems Competitive Strengths & Weaknesses
9.23 Canon Medical
9.23.1 Canon Medical Details
9.23.2 Canon Medical Major Business
9.23.3 Canon Medical Artificial Intelligence (AI) in Cancer Product and Services
9.23.4 Canon Medical Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Canon Medical Recent Developments/Updates
9.23.6 Canon Medical Competitive Strengths & Weaknesses
9.24 GE Healthcare
9.24.1 GE Healthcare Details
9.24.2 GE Healthcare Major Business
9.24.3 GE Healthcare Artificial Intelligence (AI) in Cancer Product and Services
9.24.4 GE Healthcare Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 GE Healthcare Recent Developments/Updates
9.24.6 GE Healthcare Competitive Strengths & Weaknesses
9.25 Philips
9.25.1 Philips Details
9.25.2 Philips Major Business
9.25.3 Philips Artificial Intelligence (AI) in Cancer Product and Services
9.25.4 Philips Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Philips Recent Developments/Updates
9.25.6 Philips Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Artificial Intelligence (AI) in Cancer Industry Chain
10.2 Artificial Intelligence (AI) in Cancer Upstream Analysis
10.3 Artificial Intelligence (AI) in Cancer Midstream Analysis
10.4 Artificial Intelligence (AI) in Cancer Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Artificial Intelligence (AI) in Cancer Introduction
1.2 World Artificial Intelligence (AI) in Cancer Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Artificial Intelligence (AI) in Cancer Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Intelligence (AI) in Cancer Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.3 China Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.4 Europe Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.5 Japan Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.6 South Korea Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.7 ASEAN Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.3.8 India Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Intelligence (AI) in Cancer Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.2 World Artificial Intelligence (AI) in Cancer Consumption Value by Region
2.2.1 World Artificial Intelligence (AI) in Cancer Consumption Value by Region (2021-2026)
2.2.2 World Artificial Intelligence (AI) in Cancer Consumption Value Forecast by Region (2027-2032)
2.3 United States Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.4 China Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.5 Europe Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.6 Japan Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.7 South Korea Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.8 ASEAN Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
2.9 India Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032)
3 WORLD ARTIFICIAL INTELLIGENCE (AI) IN CANCER COMPANIES COMPETITIVE ANALYSIS
3.1 World Artificial Intelligence (AI) in Cancer Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Intelligence (AI) in Cancer Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Intelligence (AI) in Cancer in 2025
3.2.3 Global Concentration Ratios (CR8) for Artificial Intelligence (AI) in Cancer in 2025
3.3 Artificial Intelligence (AI) in Cancer Company Evaluation Quadrant
3.4 Artificial Intelligence (AI) in Cancer Market: Overall Company Footprint Analysis
3.4.1 Artificial Intelligence (AI) in Cancer Market: Region Footprint
3.4.2 Artificial Intelligence (AI) in Cancer Market: Company Product Type Footprint
3.4.3 Artificial Intelligence (AI) in Cancer Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Artificial Intelligence (AI) in Cancer Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Intelligence (AI) in Cancer Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Artificial Intelligence (AI) in Cancer Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Artificial Intelligence (AI) in Cancer Consumption Value Comparison
4.2.1 United States VS China: Artificial Intelligence (AI) in Cancer Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Artificial Intelligence (AI) in Cancer Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Artificial Intelligence (AI) in Cancer Companies and Market Share, 2021-2026
4.3.1 United States Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Intelligence (AI) in Cancer Revenue, (2021-2026)
4.4 China Based Companies Artificial Intelligence (AI) in Cancer Revenue and Market Share, 2021-2026
4.4.1 China Based Artificial Intelligence (AI) in Cancer Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Intelligence (AI) in Cancer Revenue, (2021-2026)
4.5 Rest of World Based Artificial Intelligence (AI) in Cancer Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Artificial Intelligence (AI) in Cancer Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Artificial Intelligence (AI) in Cancer Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Medical Imaging?based AI
5.2.2 Digital Pathology?based AI
5.2.3 Genomics & Multi-omics AI
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Artificial Intelligence (AI) in Cancer Market Size by Type (2021-2026)
5.3.2 World Artificial Intelligence (AI) in Cancer Market Size by Type (2027-2032)
5.3.3 World Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY AI FUNCTION DEPTH
6.1 World Artificial Intelligence (AI) in Cancer Market Size Overview by AI Function Depth: 2021 VS 2025 VS 2032
6.2 Segment Introduction by AI Function Depth
6.2.1 Detection & Flagging
6.2.2 Segmentation & Quantification
6.2.3 Classification & Grading
6.2.4 Prediction & Outcome Modeling
6.2.5 Others
6.3 Market Segment by AI Function Depth
6.3.1 World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth (2021-2026)
6.3.2 World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth (2027-2032)
6.3.3 World Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth (2027-2032)
7 MARKET ANALYSIS BY PRODUCT FORM & COMMERCIAL MODEL
7.1 World Artificial Intelligence (AI) in Cancer Market Size Overview by Product Form & Commercial Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form & Commercial Model
7.2.1 Device-embedded AI Systems
7.2.2 Standalone Software / SaaS Platforms
7.2.3 AI-as-a-Service for Oncology
7.2.4 Others
7.3 Market Segment by Product Form & Commercial Model
7.3.1 World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model (2021-2026)
7.3.2 World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model (2027-2032)
7.3.3 World Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Artificial Intelligence (AI) in Cancer Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Lung Cancer
8.2.2 Breast Cancer
8.2.3 Colorectal & GI Cancers
8.2.4 Prostate & Urological Cancers
8.2.5 Hematologic & Rare Cancers
8.2.6 Others
8.3 Market Segment by Application
8.3.1 World Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026)
8.3.2 World Artificial Intelligence (AI) in Cancer Market Size by Application (2027-2032)
8.3.3 World Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 PathAI
9.1.1 PathAI Details
9.1.2 PathAI Major Business
9.1.3 PathAI Artificial Intelligence (AI) in Cancer Product and Services
9.1.4 PathAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 PathAI Recent Developments/Updates
9.1.6 PathAI Competitive Strengths & Weaknesses
9.2 PaigeAI
9.2.1 PaigeAI Details
9.2.2 PaigeAI Major Business
9.2.3 PaigeAI Artificial Intelligence (AI) in Cancer Product and Services
9.2.4 PaigeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 PaigeAI Recent Developments/Updates
9.2.6 PaigeAI Competitive Strengths & Weaknesses
9.3 Lunit
9.3.1 Lunit Details
9.3.2 Lunit Major Business
9.3.3 Lunit Artificial Intelligence (AI) in Cancer Product and Services
9.3.4 Lunit Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Lunit Recent Developments/Updates
9.3.6 Lunit Competitive Strengths & Weaknesses
9.4 INFERVISION TECHNOLOGY
9.4.1 INFERVISION TECHNOLOGY Details
9.4.2 INFERVISION TECHNOLOGY Major Business
9.4.3 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product and Services
9.4.4 INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 INFERVISION TECHNOLOGY Recent Developments/Updates
9.4.6 INFERVISION TECHNOLOGY Competitive Strengths & Weaknesses
9.5 Aidoc
9.5.1 Aidoc Details
9.5.2 Aidoc Major Business
9.5.3 Aidoc Artificial Intelligence (AI) in Cancer Product and Services
9.5.4 Aidoc Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Aidoc Recent Developments/Updates
9.5.6 Aidoc Competitive Strengths & Weaknesses
9.6 VUNO, Inc.
9.6.1 VUNO, Inc. Details
9.6.2 VUNO, Inc. Major Business
9.6.3 VUNO, Inc. Artificial Intelligence (AI) in Cancer Product and Services
9.6.4 VUNO, Inc. Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 VUNO, Inc. Recent Developments/Updates
9.6.6 VUNO, Inc. Competitive Strengths & Weaknesses
9.7 ANNALISE-AI PTY LTD
9.7.1 ANNALISE-AI PTY LTD Details
9.7.2 ANNALISE-AI PTY LTD Major Business
9.7.3 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product and Services
9.7.4 ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 ANNALISE-AI PTY LTD Recent Developments/Updates
9.7.6 ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
9.8 BioMind
9.8.1 BioMind Details
9.8.2 BioMind Major Business
9.8.3 BioMind Artificial Intelligence (AI) in Cancer Product and Services
9.8.4 BioMind Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BioMind Recent Developments/Updates
9.8.6 BioMind Competitive Strengths & Weaknesses
9.9 YITU Technology
9.9.1 YITU Technology Details
9.9.2 YITU Technology Major Business
9.9.3 YITU Technology Artificial Intelligence (AI) in Cancer Product and Services
9.9.4 YITU Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 YITU Technology Recent Developments/Updates
9.9.6 YITU Technology Competitive Strengths & Weaknesses
9.10 Shukun Technology
9.10.1 Shukun Technology Details
9.10.2 Shukun Technology Major Business
9.10.3 Shukun Technology Artificial Intelligence (AI) in Cancer Product and Services
9.10.4 Shukun Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Shukun Technology Recent Developments/Updates
9.10.6 Shukun Technology Competitive Strengths & Weaknesses
9.11 Beijing Huiyi Huiying Medical Technology
9.11.1 Beijing Huiyi Huiying Medical Technology Details
9.11.2 Beijing Huiyi Huiying Medical Technology Major Business
9.11.3 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product and Services
9.11.4 Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Beijing Huiyi Huiying Medical Technology Recent Developments/Updates
9.11.6 Beijing Huiyi Huiying Medical Technology Competitive Strengths & Weaknesses
9.12 Shenzhen Keya Medical Technology
9.12.1 Shenzhen Keya Medical Technology Details
9.12.2 Shenzhen Keya Medical Technology Major Business
9.12.3 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product and Services
9.12.4 Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Shenzhen Keya Medical Technology Recent Developments/Updates
9.12.6 Shenzhen Keya Medical Technology Competitive Strengths & Weaknesses
9.13 Densitas
9.13.1 Densitas Details
9.13.2 Densitas Major Business
9.13.3 Densitas Artificial Intelligence (AI) in Cancer Product and Services
9.13.4 Densitas Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Densitas Recent Developments/Updates
9.13.6 Densitas Competitive Strengths & Weaknesses
9.14 Volpara
9.14.1 Volpara Details
9.14.2 Volpara Major Business
9.14.3 Volpara Artificial Intelligence (AI) in Cancer Product and Services
9.14.4 Volpara Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Volpara Recent Developments/Updates
9.14.6 Volpara Competitive Strengths & Weaknesses
9.15 Niramai
9.15.1 Niramai Details
9.15.2 Niramai Major Business
9.15.3 Niramai Artificial Intelligence (AI) in Cancer Product and Services
9.15.4 Niramai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Niramai Recent Developments/Updates
9.15.6 Niramai Competitive Strengths & Weaknesses
9.16 MVision AI
9.16.1 MVision AI Details
9.16.2 MVision AI Major Business
9.16.3 MVision AI Artificial Intelligence (AI) in Cancer Product and Services
9.16.4 MVision AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 MVision AI Recent Developments/Updates
9.16.6 MVision AI Competitive Strengths & Weaknesses
9.17 MammoScreen
9.17.1 MammoScreen Details
9.17.2 MammoScreen Major Business
9.17.3 MammoScreen Artificial Intelligence (AI) in Cancer Product and Services
9.17.4 MammoScreen Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 MammoScreen Recent Developments/Updates
9.17.6 MammoScreen Competitive Strengths & Weaknesses
9.18 Perimeter Medical Imaging AI
9.18.1 Perimeter Medical Imaging AI Details
9.18.2 Perimeter Medical Imaging AI Major Business
9.18.3 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product and Services
9.18.4 Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Perimeter Medical Imaging AI Recent Developments/Updates
9.18.6 Perimeter Medical Imaging AI Competitive Strengths & Weaknesses
9.19 ICAD
9.19.1 ICAD Details
9.19.2 ICAD Major Business
9.19.3 ICAD Artificial Intelligence (AI) in Cancer Product and Services
9.19.4 ICAD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 ICAD Recent Developments/Updates
9.19.6 ICAD Competitive Strengths & Weaknesses
9.20 LungLifeAI
9.20.1 LungLifeAI Details
9.20.2 LungLifeAI Major Business
9.20.3 LungLifeAI Artificial Intelligence (AI) in Cancer Product and Services
9.20.4 LungLifeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 LungLifeAI Recent Developments/Updates
9.20.6 LungLifeAI Competitive Strengths & Weaknesses
9.21 Nanox.AI
9.21.1 Nanox.AI Details
9.21.2 Nanox.AI Major Business
9.21.3 Nanox.AI Artificial Intelligence (AI) in Cancer Product and Services
9.21.4 Nanox.AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Nanox.AI Recent Developments/Updates
9.21.6 Nanox.AI Competitive Strengths & Weaknesses
9.22 Varian Medical Systems
9.22.1 Varian Medical Systems Details
9.22.2 Varian Medical Systems Major Business
9.22.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Product and Services
9.22.4 Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Varian Medical Systems Recent Developments/Updates
9.22.6 Varian Medical Systems Competitive Strengths & Weaknesses
9.23 Canon Medical
9.23.1 Canon Medical Details
9.23.2 Canon Medical Major Business
9.23.3 Canon Medical Artificial Intelligence (AI) in Cancer Product and Services
9.23.4 Canon Medical Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Canon Medical Recent Developments/Updates
9.23.6 Canon Medical Competitive Strengths & Weaknesses
9.24 GE Healthcare
9.24.1 GE Healthcare Details
9.24.2 GE Healthcare Major Business
9.24.3 GE Healthcare Artificial Intelligence (AI) in Cancer Product and Services
9.24.4 GE Healthcare Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 GE Healthcare Recent Developments/Updates
9.24.6 GE Healthcare Competitive Strengths & Weaknesses
9.25 Philips
9.25.1 Philips Details
9.25.2 Philips Major Business
9.25.3 Philips Artificial Intelligence (AI) in Cancer Product and Services
9.25.4 Philips Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Philips Recent Developments/Updates
9.25.6 Philips Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Artificial Intelligence (AI) in Cancer Industry Chain
10.2 Artificial Intelligence (AI) in Cancer Upstream Analysis
10.3 Artificial Intelligence (AI) in Cancer Midstream Analysis
10.4 Artificial Intelligence (AI) in Cancer Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Artificial Intelligence (AI) in Cancer Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Intelligence (AI) in Cancer Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Intelligence (AI) in Cancer Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Intelligence (AI) in Cancer Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Artificial Intelligence (AI) in Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Artificial Intelligence (AI) in Cancer Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Artificial Intelligence (AI) in Cancer Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Intelligence (AI) in Cancer Players in 2025
Table 12. World Artificial Intelligence (AI) in Cancer Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Artificial Intelligence (AI) in Cancer Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Intelligence (AI) in Cancer Players
Table 15. Artificial Intelligence (AI) in Cancer Market: Company Product Type Footprint
Table 16. Artificial Intelligence (AI) in Cancer Market: Company Product Application Footprint
Table 17. Artificial Intelligence (AI) in Cancer Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Intelligence (AI) in Cancer Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Artificial Intelligence (AI) in Cancer Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Intelligence (AI) in Cancer Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Artificial Intelligence (AI) in Cancer Revenue Market Share (2021-2026)
Table 23. China Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Intelligence (AI) in Cancer Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Artificial Intelligence (AI) in Cancer Revenue Market Share (2021-2026)
Table 26. Rest of World Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Artificial Intelligence (AI) in Cancer Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Artificial Intelligence (AI) in Cancer Revenue Market Share (2021-2026)
Table 29. World Artificial Intelligence (AI) in Cancer Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Artificial Intelligence (AI) in Cancer Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Artificial Intelligence (AI) in Cancer Market Size by Type (2027-2032) & (USD Million)
Table 32. World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth, (USD Million), 2021 & 2025 & 2032
Table 33. World Artificial Intelligence (AI) in Cancer Market Size Value by AI Function Depth (2021-2026) & (USD Million)
Table 34. World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth (2027-2032) & (USD Million)
Table 35. World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Artificial Intelligence (AI) in Cancer Market Size Value by Product Form & Commercial Model (2021-2026) & (USD Million)
Table 37. World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model (2027-2032) & (USD Million)
Table 38. World Artificial Intelligence (AI) in Cancer Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & (USD Million)
Table 40. World Artificial Intelligence (AI) in Cancer Market Size by Application (2027-2032) & (USD Million)
Table 41. PathAI Basic Information, Manufacturing Base and Competitors
Table 42. PathAI Major Business
Table 43. PathAI Artificial Intelligence (AI) in Cancer Product and Services
Table 44. PathAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. PathAI Recent Developments/Updates
Table 46. PathAI Competitive Strengths & Weaknesses
Table 47. PaigeAI Basic Information, Manufacturing Base and Competitors
Table 48. PaigeAI Major Business
Table 49. PaigeAI Artificial Intelligence (AI) in Cancer Product and Services
Table 50. PaigeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. PaigeAI Recent Developments/Updates
Table 52. PaigeAI Competitive Strengths & Weaknesses
Table 53. Lunit Basic Information, Manufacturing Base and Competitors
Table 54. Lunit Major Business
Table 55. Lunit Artificial Intelligence (AI) in Cancer Product and Services
Table 56. Lunit Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Lunit Recent Developments/Updates
Table 58. Lunit Competitive Strengths & Weaknesses
Table 59. INFERVISION TECHNOLOGY Basic Information, Manufacturing Base and Competitors
Table 60. INFERVISION TECHNOLOGY Major Business
Table 61. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product and Services
Table 62. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. INFERVISION TECHNOLOGY Recent Developments/Updates
Table 64. INFERVISION TECHNOLOGY Competitive Strengths & Weaknesses
Table 65. Aidoc Basic Information, Manufacturing Base and Competitors
Table 66. Aidoc Major Business
Table 67. Aidoc Artificial Intelligence (AI) in Cancer Product and Services
Table 68. Aidoc Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Aidoc Recent Developments/Updates
Table 70. Aidoc Competitive Strengths & Weaknesses
Table 71. VUNO, Inc. Basic Information, Manufacturing Base and Competitors
Table 72. VUNO, Inc. Major Business
Table 73. VUNO, Inc. Artificial Intelligence (AI) in Cancer Product and Services
Table 74. VUNO, Inc. Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. VUNO, Inc. Recent Developments/Updates
Table 76. VUNO, Inc. Competitive Strengths & Weaknesses
Table 77. ANNALISE-AI PTY LTD Basic Information, Manufacturing Base and Competitors
Table 78. ANNALISE-AI PTY LTD Major Business
Table 79. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product and Services
Table 80. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ANNALISE-AI PTY LTD Recent Developments/Updates
Table 82. ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
Table 83. BioMind Basic Information, Manufacturing Base and Competitors
Table 84. BioMind Major Business
Table 85. BioMind Artificial Intelligence (AI) in Cancer Product and Services
Table 86. BioMind Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BioMind Recent Developments/Updates
Table 88. BioMind Competitive Strengths & Weaknesses
Table 89. YITU Technology Basic Information, Manufacturing Base and Competitors
Table 90. YITU Technology Major Business
Table 91. YITU Technology Artificial Intelligence (AI) in Cancer Product and Services
Table 92. YITU Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. YITU Technology Recent Developments/Updates
Table 94. YITU Technology Competitive Strengths & Weaknesses
Table 95. Shukun Technology Basic Information, Manufacturing Base and Competitors
Table 96. Shukun Technology Major Business
Table 97. Shukun Technology Artificial Intelligence (AI) in Cancer Product and Services
Table 98. Shukun Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Shukun Technology Recent Developments/Updates
Table 100. Shukun Technology Competitive Strengths & Weaknesses
Table 101. Beijing Huiyi Huiying Medical Technology Basic Information, Manufacturing Base and Competitors
Table 102. Beijing Huiyi Huiying Medical Technology Major Business
Table 103. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product and Services
Table 104. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Beijing Huiyi Huiying Medical Technology Recent Developments/Updates
Table 106. Beijing Huiyi Huiying Medical Technology Competitive Strengths & Weaknesses
Table 107. Shenzhen Keya Medical Technology Basic Information, Manufacturing Base and Competitors
Table 108. Shenzhen Keya Medical Technology Major Business
Table 109. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product and Services
Table 110. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Shenzhen Keya Medical Technology Recent Developments/Updates
Table 112. Shenzhen Keya Medical Technology Competitive Strengths & Weaknesses
Table 113. Densitas Basic Information, Manufacturing Base and Competitors
Table 114. Densitas Major Business
Table 115. Densitas Artificial Intelligence (AI) in Cancer Product and Services
Table 116. Densitas Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Densitas Recent Developments/Updates
Table 118. Densitas Competitive Strengths & Weaknesses
Table 119. Volpara Basic Information, Manufacturing Base and Competitors
Table 120. Volpara Major Business
Table 121. Volpara Artificial Intelligence (AI) in Cancer Product and Services
Table 122. Volpara Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Volpara Recent Developments/Updates
Table 124. Volpara Competitive Strengths & Weaknesses
Table 125. Niramai Basic Information, Manufacturing Base and Competitors
Table 126. Niramai Major Business
Table 127. Niramai Artificial Intelligence (AI) in Cancer Product and Services
Table 128. Niramai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Niramai Recent Developments/Updates
Table 130. Niramai Competitive Strengths & Weaknesses
Table 131. MVision AI Basic Information, Manufacturing Base and Competitors
Table 132. MVision AI Major Business
Table 133. MVision AI Artificial Intelligence (AI) in Cancer Product and Services
Table 134. MVision AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. MVision AI Recent Developments/Updates
Table 136. MVision AI Competitive Strengths & Weaknesses
Table 137. MammoScreen Basic Information, Manufacturing Base and Competitors
Table 138. MammoScreen Major Business
Table 139. MammoScreen Artificial Intelligence (AI) in Cancer Product and Services
Table 140. MammoScreen Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. MammoScreen Recent Developments/Updates
Table 142. MammoScreen Competitive Strengths & Weaknesses
Table 143. Perimeter Medical Imaging AI Basic Information, Manufacturing Base and Competitors
Table 144. Perimeter Medical Imaging AI Major Business
Table 145. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product and Services
Table 146. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Perimeter Medical Imaging AI Recent Developments/Updates
Table 148. Perimeter Medical Imaging AI Competitive Strengths & Weaknesses
Table 149. ICAD Basic Information, Manufacturing Base and Competitors
Table 150. ICAD Major Business
Table 151. ICAD Artificial Intelligence (AI) in Cancer Product and Services
Table 152. ICAD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. ICAD Recent Developments/Updates
Table 154. ICAD Competitive Strengths & Weaknesses
Table 155. LungLifeAI Basic Information, Manufacturing Base and Competitors
Table 156. LungLifeAI Major Business
Table 157. LungLifeAI Artificial Intelligence (AI) in Cancer Product and Services
Table 158. LungLifeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. LungLifeAI Recent Developments/Updates
Table 160. LungLifeAI Competitive Strengths & Weaknesses
Table 161. Nanox.AI Basic Information, Manufacturing Base and Competitors
Table 162. Nanox.AI Major Business
Table 163. Nanox.AI Artificial Intelligence (AI) in Cancer Product and Services
Table 164. Nanox.AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Nanox.AI Recent Developments/Updates
Table 166. Nanox.AI Competitive Strengths & Weaknesses
Table 167. Varian Medical Systems Basic Information, Manufacturing Base and Competitors
Table 168. Varian Medical Systems Major Business
Table 169. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product and Services
Table 170. Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Varian Medical Systems Recent Developments/Updates
Table 172. Varian Medical Systems Competitive Strengths & Weaknesses
Table 173. Canon Medical Basic Information, Manufacturing Base and Competitors
Table 174. Canon Medical Major Business
Table 175. Canon Medical Artificial Intelligence (AI) in Cancer Product and Services
Table 176. Canon Medical Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Canon Medical Recent Developments/Updates
Table 178. Canon Medical Competitive Strengths & Weaknesses
Table 179. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 180. GE Healthcare Major Business
Table 181. GE Healthcare Artificial Intelligence (AI) in Cancer Product and Services
Table 182. GE Healthcare Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. GE Healthcare Recent Developments/Updates
Table 184. GE Healthcare Competitive Strengths & Weaknesses
Table 185. Philips Basic Information, Manufacturing Base and Competitors
Table 186. Philips Major Business
Table 187. Philips Artificial Intelligence (AI) in Cancer Product and Services
Table 188. Philips Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Philips Recent Developments/Updates
Table 190. Philips Competitive Strengths & Weaknesses
Table 191. Global Key Players of Artificial Intelligence (AI) in Cancer Upstream (Raw Materials)
Table 192. Global Artificial Intelligence (AI) in Cancer Typical Customers
Table 1. World Artificial Intelligence (AI) in Cancer Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Intelligence (AI) in Cancer Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Intelligence (AI) in Cancer Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Intelligence (AI) in Cancer Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Artificial Intelligence (AI) in Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Artificial Intelligence (AI) in Cancer Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Artificial Intelligence (AI) in Cancer Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Intelligence (AI) in Cancer Players in 2025
Table 12. World Artificial Intelligence (AI) in Cancer Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Artificial Intelligence (AI) in Cancer Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Intelligence (AI) in Cancer Players
Table 15. Artificial Intelligence (AI) in Cancer Market: Company Product Type Footprint
Table 16. Artificial Intelligence (AI) in Cancer Market: Company Product Application Footprint
Table 17. Artificial Intelligence (AI) in Cancer Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Intelligence (AI) in Cancer Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Artificial Intelligence (AI) in Cancer Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Intelligence (AI) in Cancer Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Artificial Intelligence (AI) in Cancer Revenue Market Share (2021-2026)
Table 23. China Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Intelligence (AI) in Cancer Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Artificial Intelligence (AI) in Cancer Revenue Market Share (2021-2026)
Table 26. Rest of World Based Artificial Intelligence (AI) in Cancer Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Artificial Intelligence (AI) in Cancer Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Artificial Intelligence (AI) in Cancer Revenue Market Share (2021-2026)
Table 29. World Artificial Intelligence (AI) in Cancer Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Artificial Intelligence (AI) in Cancer Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Artificial Intelligence (AI) in Cancer Market Size by Type (2027-2032) & (USD Million)
Table 32. World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth, (USD Million), 2021 & 2025 & 2032
Table 33. World Artificial Intelligence (AI) in Cancer Market Size Value by AI Function Depth (2021-2026) & (USD Million)
Table 34. World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth (2027-2032) & (USD Million)
Table 35. World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Artificial Intelligence (AI) in Cancer Market Size Value by Product Form & Commercial Model (2021-2026) & (USD Million)
Table 37. World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model (2027-2032) & (USD Million)
Table 38. World Artificial Intelligence (AI) in Cancer Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Artificial Intelligence (AI) in Cancer Market Size by Application (2021-2026) & (USD Million)
Table 40. World Artificial Intelligence (AI) in Cancer Market Size by Application (2027-2032) & (USD Million)
Table 41. PathAI Basic Information, Manufacturing Base and Competitors
Table 42. PathAI Major Business
Table 43. PathAI Artificial Intelligence (AI) in Cancer Product and Services
Table 44. PathAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. PathAI Recent Developments/Updates
Table 46. PathAI Competitive Strengths & Weaknesses
Table 47. PaigeAI Basic Information, Manufacturing Base and Competitors
Table 48. PaigeAI Major Business
Table 49. PaigeAI Artificial Intelligence (AI) in Cancer Product and Services
Table 50. PaigeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. PaigeAI Recent Developments/Updates
Table 52. PaigeAI Competitive Strengths & Weaknesses
Table 53. Lunit Basic Information, Manufacturing Base and Competitors
Table 54. Lunit Major Business
Table 55. Lunit Artificial Intelligence (AI) in Cancer Product and Services
Table 56. Lunit Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Lunit Recent Developments/Updates
Table 58. Lunit Competitive Strengths & Weaknesses
Table 59. INFERVISION TECHNOLOGY Basic Information, Manufacturing Base and Competitors
Table 60. INFERVISION TECHNOLOGY Major Business
Table 61. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Product and Services
Table 62. INFERVISION TECHNOLOGY Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. INFERVISION TECHNOLOGY Recent Developments/Updates
Table 64. INFERVISION TECHNOLOGY Competitive Strengths & Weaknesses
Table 65. Aidoc Basic Information, Manufacturing Base and Competitors
Table 66. Aidoc Major Business
Table 67. Aidoc Artificial Intelligence (AI) in Cancer Product and Services
Table 68. Aidoc Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Aidoc Recent Developments/Updates
Table 70. Aidoc Competitive Strengths & Weaknesses
Table 71. VUNO, Inc. Basic Information, Manufacturing Base and Competitors
Table 72. VUNO, Inc. Major Business
Table 73. VUNO, Inc. Artificial Intelligence (AI) in Cancer Product and Services
Table 74. VUNO, Inc. Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. VUNO, Inc. Recent Developments/Updates
Table 76. VUNO, Inc. Competitive Strengths & Weaknesses
Table 77. ANNALISE-AI PTY LTD Basic Information, Manufacturing Base and Competitors
Table 78. ANNALISE-AI PTY LTD Major Business
Table 79. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Product and Services
Table 80. ANNALISE-AI PTY LTD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ANNALISE-AI PTY LTD Recent Developments/Updates
Table 82. ANNALISE-AI PTY LTD Competitive Strengths & Weaknesses
Table 83. BioMind Basic Information, Manufacturing Base and Competitors
Table 84. BioMind Major Business
Table 85. BioMind Artificial Intelligence (AI) in Cancer Product and Services
Table 86. BioMind Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BioMind Recent Developments/Updates
Table 88. BioMind Competitive Strengths & Weaknesses
Table 89. YITU Technology Basic Information, Manufacturing Base and Competitors
Table 90. YITU Technology Major Business
Table 91. YITU Technology Artificial Intelligence (AI) in Cancer Product and Services
Table 92. YITU Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. YITU Technology Recent Developments/Updates
Table 94. YITU Technology Competitive Strengths & Weaknesses
Table 95. Shukun Technology Basic Information, Manufacturing Base and Competitors
Table 96. Shukun Technology Major Business
Table 97. Shukun Technology Artificial Intelligence (AI) in Cancer Product and Services
Table 98. Shukun Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Shukun Technology Recent Developments/Updates
Table 100. Shukun Technology Competitive Strengths & Weaknesses
Table 101. Beijing Huiyi Huiying Medical Technology Basic Information, Manufacturing Base and Competitors
Table 102. Beijing Huiyi Huiying Medical Technology Major Business
Table 103. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Product and Services
Table 104. Beijing Huiyi Huiying Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Beijing Huiyi Huiying Medical Technology Recent Developments/Updates
Table 106. Beijing Huiyi Huiying Medical Technology Competitive Strengths & Weaknesses
Table 107. Shenzhen Keya Medical Technology Basic Information, Manufacturing Base and Competitors
Table 108. Shenzhen Keya Medical Technology Major Business
Table 109. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Product and Services
Table 110. Shenzhen Keya Medical Technology Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Shenzhen Keya Medical Technology Recent Developments/Updates
Table 112. Shenzhen Keya Medical Technology Competitive Strengths & Weaknesses
Table 113. Densitas Basic Information, Manufacturing Base and Competitors
Table 114. Densitas Major Business
Table 115. Densitas Artificial Intelligence (AI) in Cancer Product and Services
Table 116. Densitas Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Densitas Recent Developments/Updates
Table 118. Densitas Competitive Strengths & Weaknesses
Table 119. Volpara Basic Information, Manufacturing Base and Competitors
Table 120. Volpara Major Business
Table 121. Volpara Artificial Intelligence (AI) in Cancer Product and Services
Table 122. Volpara Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Volpara Recent Developments/Updates
Table 124. Volpara Competitive Strengths & Weaknesses
Table 125. Niramai Basic Information, Manufacturing Base and Competitors
Table 126. Niramai Major Business
Table 127. Niramai Artificial Intelligence (AI) in Cancer Product and Services
Table 128. Niramai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Niramai Recent Developments/Updates
Table 130. Niramai Competitive Strengths & Weaknesses
Table 131. MVision AI Basic Information, Manufacturing Base and Competitors
Table 132. MVision AI Major Business
Table 133. MVision AI Artificial Intelligence (AI) in Cancer Product and Services
Table 134. MVision AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. MVision AI Recent Developments/Updates
Table 136. MVision AI Competitive Strengths & Weaknesses
Table 137. MammoScreen Basic Information, Manufacturing Base and Competitors
Table 138. MammoScreen Major Business
Table 139. MammoScreen Artificial Intelligence (AI) in Cancer Product and Services
Table 140. MammoScreen Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. MammoScreen Recent Developments/Updates
Table 142. MammoScreen Competitive Strengths & Weaknesses
Table 143. Perimeter Medical Imaging AI Basic Information, Manufacturing Base and Competitors
Table 144. Perimeter Medical Imaging AI Major Business
Table 145. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Product and Services
Table 146. Perimeter Medical Imaging AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Perimeter Medical Imaging AI Recent Developments/Updates
Table 148. Perimeter Medical Imaging AI Competitive Strengths & Weaknesses
Table 149. ICAD Basic Information, Manufacturing Base and Competitors
Table 150. ICAD Major Business
Table 151. ICAD Artificial Intelligence (AI) in Cancer Product and Services
Table 152. ICAD Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. ICAD Recent Developments/Updates
Table 154. ICAD Competitive Strengths & Weaknesses
Table 155. LungLifeAI Basic Information, Manufacturing Base and Competitors
Table 156. LungLifeAI Major Business
Table 157. LungLifeAI Artificial Intelligence (AI) in Cancer Product and Services
Table 158. LungLifeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. LungLifeAI Recent Developments/Updates
Table 160. LungLifeAI Competitive Strengths & Weaknesses
Table 161. Nanox.AI Basic Information, Manufacturing Base and Competitors
Table 162. Nanox.AI Major Business
Table 163. Nanox.AI Artificial Intelligence (AI) in Cancer Product and Services
Table 164. Nanox.AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Nanox.AI Recent Developments/Updates
Table 166. Nanox.AI Competitive Strengths & Weaknesses
Table 167. Varian Medical Systems Basic Information, Manufacturing Base and Competitors
Table 168. Varian Medical Systems Major Business
Table 169. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product and Services
Table 170. Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Varian Medical Systems Recent Developments/Updates
Table 172. Varian Medical Systems Competitive Strengths & Weaknesses
Table 173. Canon Medical Basic Information, Manufacturing Base and Competitors
Table 174. Canon Medical Major Business
Table 175. Canon Medical Artificial Intelligence (AI) in Cancer Product and Services
Table 176. Canon Medical Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Canon Medical Recent Developments/Updates
Table 178. Canon Medical Competitive Strengths & Weaknesses
Table 179. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 180. GE Healthcare Major Business
Table 181. GE Healthcare Artificial Intelligence (AI) in Cancer Product and Services
Table 182. GE Healthcare Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. GE Healthcare Recent Developments/Updates
Table 184. GE Healthcare Competitive Strengths & Weaknesses
Table 185. Philips Basic Information, Manufacturing Base and Competitors
Table 186. Philips Major Business
Table 187. Philips Artificial Intelligence (AI) in Cancer Product and Services
Table 188. Philips Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Philips Recent Developments/Updates
Table 190. Philips Competitive Strengths & Weaknesses
Table 191. Global Key Players of Artificial Intelligence (AI) in Cancer Upstream (Raw Materials)
Table 192. Global Artificial Intelligence (AI) in Cancer Typical Customers
LIST OF FIGURES
Figure 1. Artificial Intelligence (AI) in Cancer Picture
Figure 2. World Artificial Intelligence (AI) in Cancer Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Artificial Intelligence (AI) in Cancer Total Revenue (2021-2032) & (USD Million)
Figure 4. World Artificial Intelligence (AI) in Cancer Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 13. Artificial Intelligence (AI) in Cancer Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 16. World Artificial Intelligence (AI) in Cancer Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 18. China Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 23. India Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Artificial Intelligence (AI) in Cancer by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Intelligence (AI) in Cancer Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Intelligence (AI) in Cancer Markets in 2025
Figure 27. United States VS China: Artificial Intelligence (AI) in Cancer Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Artificial Intelligence (AI) in Cancer Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Artificial Intelligence (AI) in Cancer Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Type in 2025
Figure 31. Medical Imaging?based AI
Figure 32. Digital Pathology?based AI
Figure 33. Genomics & Multi-omics AI
Figure 34. Others
Figure 35. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2032)
Figure 36. World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth, (USD Million), 2021 & 2025 & 2032
Figure 37. World Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth in 2025
Figure 38. Detection & Flagging
Figure 39. Segmentation & Quantification
Figure 40. Classification & Grading
Figure 41. Prediction & Outcome Modeling
Figure 42. Others
Figure 43. World Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth (2021-2032)
Figure 44. World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model, (USD Million), 2021 & 2025 & 2032
Figure 45. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model in 2025
Figure 46. Device-embedded AI Systems
Figure 47. Standalone Software / SaaS Platforms
Figure 48. AI-as-a-Service for Oncology
Figure 49. Others
Figure 50. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model (2021-2032)
Figure 51. World Artificial Intelligence (AI) in Cancer Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Application in 2025
Figure 53. Lung Cancer
Figure 54. Breast Cancer
Figure 55. Colorectal & GI Cancers
Figure 56. Prostate & Urological Cancers
Figure 57. Hematologic & Rare Cancers
Figure 58. Others
Figure 59. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2032)
Figure 60. Artificial Intelligence (AI) in Cancer Industrial Chain
Figure 61. Methodology
Figure 62. Research Process and Data Source
Figure 1. Artificial Intelligence (AI) in Cancer Picture
Figure 2. World Artificial Intelligence (AI) in Cancer Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Artificial Intelligence (AI) in Cancer Total Revenue (2021-2032) & (USD Million)
Figure 4. World Artificial Intelligence (AI) in Cancer Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Artificial Intelligence (AI) in Cancer Revenue (2021-2032) & (USD Million)
Figure 13. Artificial Intelligence (AI) in Cancer Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 16. World Artificial Intelligence (AI) in Cancer Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 18. China Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 23. India Artificial Intelligence (AI) in Cancer Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Artificial Intelligence (AI) in Cancer by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Intelligence (AI) in Cancer Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Intelligence (AI) in Cancer Markets in 2025
Figure 27. United States VS China: Artificial Intelligence (AI) in Cancer Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Artificial Intelligence (AI) in Cancer Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Artificial Intelligence (AI) in Cancer Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Type in 2025
Figure 31. Medical Imaging?based AI
Figure 32. Digital Pathology?based AI
Figure 33. Genomics & Multi-omics AI
Figure 34. Others
Figure 35. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Type (2021-2032)
Figure 36. World Artificial Intelligence (AI) in Cancer Market Size by AI Function Depth, (USD Million), 2021 & 2025 & 2032
Figure 37. World Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth in 2025
Figure 38. Detection & Flagging
Figure 39. Segmentation & Quantification
Figure 40. Classification & Grading
Figure 41. Prediction & Outcome Modeling
Figure 42. Others
Figure 43. World Artificial Intelligence (AI) in Cancer Market Size Market Share by AI Function Depth (2021-2032)
Figure 44. World Artificial Intelligence (AI) in Cancer Market Size by Product Form & Commercial Model, (USD Million), 2021 & 2025 & 2032
Figure 45. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model in 2025
Figure 46. Device-embedded AI Systems
Figure 47. Standalone Software / SaaS Platforms
Figure 48. AI-as-a-Service for Oncology
Figure 49. Others
Figure 50. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Product Form & Commercial Model (2021-2032)
Figure 51. World Artificial Intelligence (AI) in Cancer Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 52. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Application in 2025
Figure 53. Lung Cancer
Figure 54. Breast Cancer
Figure 55. Colorectal & GI Cancers
Figure 56. Prostate & Urological Cancers
Figure 57. Hematologic & Rare Cancers
Figure 58. Others
Figure 59. World Artificial Intelligence (AI) in Cancer Market Size Market Share by Application (2021-2032)
Figure 60. Artificial Intelligence (AI) in Cancer Industrial Chain
Figure 61. Methodology
Figure 62. Research Process and Data Source
